FDA alerts healthcare professionals about-CardioGen-82 -PET
The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals to stop using CardioGen-82 for cardiac positron emission tomography (PET) scans due to radiation concerns. The manufacturer, Bracco Diagnostics, Inc. has decided to voluntarily recall CardioGen-82.
FDA alerts healthcare professionals about-CardioGen-82 -PET
![]()
Reviewed by Sumer Sethi
on
Saturday, July 30, 2011
Rating:
Sumer Sethi
Unique blend of academic excellence and entrepreneurship, heading leading firms in India- Teleradiology Providers, pioneering company providing teleradiology services and DAMS (Delhi Academy of Medical Sciences) Premier test preparation institute in India for MD/MS/MCI preparation. He has also been an invited faculty member at various conferences, including Teleradiology in IRIA 2008 and 2011, Hospital Build Middle East, Congress of the Brain Tumor Radiology in Neuro-oncology Society. Dr. Sethi is Editor-in-Chief of Internet Journal of Radiology. He has a keen interest in Web 2.0 technologies and in maintaining his famous radiology blog, which has been featured in multiple international journals.
2 comments:
Because 2 patients were found to have got much high radiation dose as the rubidium broke down into strontium which has a much longer half life and lead to the increased dosage.
because two patients were found to have got increased radiation dose as the rubidium degraded into strontium which has a longer half life and lead to the increased dose.
Post a Comment